Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2022 Aug 3;18(8):e1009903. doi: 10.1371/journal.pgen.1009903

Comprehensive analysis of the circadian nuclear and cytoplasmic transcriptome in mouse liver

Clémence Hurni 1, Benjamin D Weger 1, Cédric Gobet 1, Felix Naef 1,*
Editor: Achim Kramer2
PMCID: PMC9377612  PMID: 35921362

Abstract

In eukaryotes, RNA is synthesised in the nucleus, spliced, and exported to the cytoplasm where it is translated and finally degraded. Any of these steps could be subject to temporal regulation during the circadian cycle, resulting in daily fluctuations of RNA accumulation and affecting the distribution of transcripts in different subcellular compartments. Our study analysed the nuclear and cytoplasmic, poly(A) and total transcriptomes of mouse livers collected over the course of a day. These data provide a genome-wide temporal inventory of enrichment in subcellular RNA, and revealed specific signatures of splicing, nuclear export and cytoplasmic mRNA stability related to transcript and gene lengths. Combined with a mathematical model describing rhythmic RNA profiles, we could test the rhythmicity of export rates and cytoplasmic degradation rates of approximately 1400 genes. With nuclear export times usually much shorter than cytoplasmic half-lives, we found that nuclear export contributes to the modulation and generation of rhythmic profiles of 10% of the cycling nuclear mRNAs. This study contributes to a better understanding of the dynamic regulation of the transcriptome during the day-night cycle.

Author summary

Why was this study done?

  • The circadian clock coordinates temporal gene expression programs to synchronise cellular and physiological functions with environmental time.

  • The circadian clock impinges on many layers of gene regulation, from transcription to mRNA degradation in the cytoplasm.

  • Specifically, whether temporal modulation of nuclear export could influence rhythmic mRNA expression was not known.

What did the researchers do and find?

  • We sequenced RNA from nuclear and cytoplasmic fractions from mouse livers sampled at different times of the day.

  • Using a mathematical model describing temporal accumulation profiles of pre-mRNA, nuclear mRNA and cytoplasmic mRNA, we could estimate the nuclear export rates and cytoplasmic degradation rates of approximately 1400 genes.

  • We observed rhythmic patterns in the nucleus that most likely originate from a rhythmic regulation of the nuclear export rate, affecting approximately 10% of the oscillations of the nuclear transcriptome in the liver.

What do these findings mean?

  • Our fractionated RNA analysis contributes to a better understanding of the dynamic regulation of the transcriptome during the daily cycle.

  • The majority of the RNA transcripts are exported to the cytoplasm in less than 30 minutes, however, some are retained in the nucleus for several hours. Thus, cellular fractionation allows a finer resolution of temporal profiles in the different subcellular compartments, which is otherwise masked at bulk-level.

Introduction

Every step of the RNA life cycle is tightly regulated to ensure proper cellular function, including transcription, co- and post-transcriptional splicing, nuclear export, and cytoplasmic degradation. Collectively, the balance of production and elimination rates determines the abundance of RNA species (e.g. pre-mRNA, polyadenylated pre-mRNA, mRNA) in a given subcellular compartment (e.g. nucleus, cytoplasm) [1]. Studies based on snapshot images of subcellular RNA distributions, either obtained by single-molecule RNA-FISH (smFISH) [2], or by RNA-seq of fractionated cells, allowed to characterise nuclear and cytoplasmic transcriptomes [36], revealing diverse patterns of subcellular localisation for different RNA subclasses. Interestingly, a study in the mouse liver showed that approximately 10% of protein coding transcripts were retained in the nucleus, efficiently buffering cytoplasmic noise associated with stochastic transcription [4].

RNA processing rates, and particularly mRNA degradation rates have been estimated in cells either from transcriptional blockage experiments [7] or a pulse-chase strategy to label nascent transcripts during a short period of time [8]. To estimate life times, RNA levels are typically fitted to exponential functions. Alternatively, mathematical modelling using ordinary differential equations to jointly describe pre-mRNA and mRNA levels can indirectly infer kinetic parameters of RNA processing steps in a label-free and genome-wide manner [9]; however, dynamic datasets reflecting different cellular states are needed to identify the parameters, for instance during cell cycle, cell differentiation [10], or at different circadian time-points [11,12]. Our laboratory previously developed a mathematical model describing the temporal profiles of pre-mRNA and mRNA from total RNA-seq, which uses the periodicity of circadian cycles and the relationship between peak times and relative amplitudes to infer the production and the decay terms; this study allowed the identification of hundreds of post-transcriptionally generated rhythmic mRNA profiles [12].

Among mouse tissues, the liver has the highest number of cycling mRNA [13], and the rhythmic patterns are driven by the endogenous circadian clock as well as by the fasting/feeding cycle [1416]. The circadian clock is a self-sustained transcription-translation feedback oscillator [17,18]. In mammals, the network consists of the CLOCK/BMAL1 transcription factors dimer which promotes the expression of its own repressors Cryptochromes (CRY1 and CRY2) and Periods (PER1 and PER2), generating cycling negative feedback loops with a period of approximately 24 hours. A second feedback loop is composed of the complex CLOCK/BMAL1 activating the expression of target genes such as Rev-Erbα,β, which repress the expression of BMAL1. The molecular clock also targets thousands of downstream clock-controlled genes to couple circadian cycles and physiological functions [19,20].

In the circadian context, rhythmic transcription often underlies rhythmic gene expression, and has been extensively studied in mouse liver [2123]. Interestingly, rhythmic transcription does not account for the rhythmic accumulation of all mRNAs, implying regulation at the post-transcriptional level. Indeed, the rates regulating the RNA processing steps often adapt to external inputs such as temperature shifts [24], nutrient levels [4], inflammation [5], or time of the day [11,12]. In principle, every step during the RNA life-cycle could be regulated temporally, contributing to rhythmic gene expression. The extent of which post-transcriptional regulation contributes to circadian gene expression is debated, varying from 15% [21,25] to 70% [22]. Conversely, many rhythmically transcribed genes do not have corresponding cycling mRNA [22] or protein [26], suggesting that the oscillatory amplitudes are damped as rhythm propagates from early to later steps of gene expression [27].

This study aims at understanding the circadian dynamics of RNA regulatory steps in mouse liver. More specifically, we focus on nuclear export and cytoplasmic degradation. We performed RNA-sequencing of polyadenylated and ribo-depleted total RNA purified from nuclear and cytoplasmic fractions of mouse liver samples collected every 4 hours along a full day cycle. This dataset provides a genome-wide and temporal inventory of RNA levels in two subcellular compartments. At the static (non-temporal) level, we found a relationship between the transcript length and the localisation, with long transcripts being enriched in the nucleus. Additionally, gene length influences the proportion of co- and post-transcriptional splicing. By modelling the rhythmic profiles (amplitudes and phases) of nuclear pre-mRNA, nuclear mRNA, and cytoplasmic mRNA, we estimated the export rates and cytoplasmic degradation rates of approximately 1400 genes. We additionally uncovered rhythmic patterns in the nucleus that suggest a rhythmic nuclear export. Moreover, this post-transcriptional regulation step not only contributes to amplifying the amplitude of highly rhythmic genes but also generates de novo rhythms, and is predicted to influence the temporal profiles of approximately 10% of the rhythmic nuclear transcriptome.

Results

Global characteristics of Poly(A) and Total RNA populations in hepatic nuclear and cytoplasmic fractions

To characterise the circadian kinetics of RNA regulatory processes occurring in different cellular compartments, we isolated RNA from nuclear (Nuc / N) and cytoplasmic (Cyt / C) fractions from mouse livers sampled every 4 hours during two consecutive days (Fig 1A). We sequenced ribosome-depleted total RNA (T) and polyadenylated RNA (A). As a control, we also extracted RNA from unfractionated samples (Unf / U). We quantified the transcript levels using the pseudo-alignment algorithm implemented in Kallisto [28] (S1 Table), by providing as a reference the annotation of transcript sequences (isoform) of both pre-mRNA (intronic and exonic regions, labelled I) and mRNA (exonic regions only, labelled E). Nuclear Total pre-mRNA (NTI), Nuclear Poly(A) mRNA (NAE), and Cytoplasmic Poly(A) mRNA (CAE) were used in our simplified model describing the sequential events occurring along the RNA lifecycle (Fig 1B). This includes the steps of pre-mRNA processing (splicing + polyadenylation), export of nuclear mRNA, and degradation of cytoplasmic mRNA. We reduced the complexity of the RNA-seq quantification performed at the transcript-level by either summing the counts of all the expressed isoforms of a gene, or of all the isoforms belonging to the same biotype (S1 Table, see Methods). The counts estimated by Kallisto were further normalised by the gene length to obtain a quantification akin to reads per kilobase per million (RPKM) (S2 and S3 Tables, see Methods). Finally, we calibrated the nuclear-to-cytoplasmic ratio using a previously published dataset, where RNA-seq counts were scaled based on smFISH quantifications of mRNA copies per cell [4].

Fig 1. Global characteristics of Poly(A) and Total RNA populations in nuclear and cytoplasmic fractions.

Fig 1

A: Experimental design: 12 WT mice were kept in a 12:12 light-dark cycle. Food was given only during the dark phase (active phase). The night-restricted feeding regimen started 3 days prior to the sampling. Livers were collected every 4 hours (n = 2), homogenised, and centrifuged in a sucrose cushion as described in [23]. RNA from cytoplasmic and nuclear fraction were extracted. rRNA-depleted Total RNA (T) and Polyadenylated RNA (A) from nuclear and cytoplasmic fractions were sequenced. Total RNA from unfractionated liver tissues was also sequenced as an internal reference set. B: Representation of each RNA processing step modelled in this study: starting with the transcription by RNA Polymerase II (at a rate T), splicing of the introns (red segment) and addition of a poly(A) tail at the 3’ end (s), export to the cytoplasm (e), and degradation (γ). p = pre-mRNA, m = nuclear polyadenylated mRNA, M = cytoplasmic mRNA. C: Principal Component Analysis using mRNA (signal from exonic regions only). PC1 separates nuclear from cytoplasmic samples, and PC2 separates Total from Poly(A) samples. Each datapoint represents one time point. D: Percentage of reads mapping on pre-mRNA or mRNA transcripts in each condition (up). Proportion of RPKM (reads normalised by gene length) of protein coding transcripts mapping on pre-mRNA and mRNA (bottom). E: Fraction of each biotype in each RNA sample. Solid lines represent mRNA (first bar), dotted lines represent pre-mRNA (second bar). Pre-mRNA from cytoplasmic fractions are not shown.

Principal Component Analysis (PCA) on the mRNA measurements shows that the first two components readily split the types of samples: indeed, subcellular localisation explains most of the variation between samples (64%, Fig 1C). Unfractionated samples lie between nuclear and cytoplasmic samples on the first principal component (PC1), although closer to cytoplasmic RNA. PC2 accounts for 15% of the variability, which is mainly related to differences in the type of RNA (Poly(A) versus Total). In comparison, the temporal variation is significantly smaller (PC4 and PC5, < 1.5% each).

The Nuclear Total RNA population (NT) includes all the transcripts found in the nucleus, from nascent transcripts to fully transcribed polyadenylated mature RNAs. As expected, the proportion of intron versus exon reads was the highest in the NT sample, and lowest in the cytoplasmic fraction (Fig 1D). In terms of reads (reflecting the mass of the corresponding RNA), approximately 75% of the reads align to pre-mRNA sequences. These proportions are similar to what has been previously described in mouse liver for nuclear total RNA [29]. Nuclear Poly(A) RNA population (NA) represents the population of fully-transcribed and polyadenylated transcripts. Interestingly, 45% of these reads map on pre-mRNA (Fig 1D). When reads are normalised by the gene length (RPKM), this showed that about 1 in 8 polyadenylated transcripts in the nucleus were still not fully spliced. Note that in Fig 1D, we only reported fractions of protein coding transcripts to avoid biases associated with the different compositions of RNA biotypes in different fractions (Fig 1E). Indeed, even if most of the detected RNA are protein coding transcripts, making up to 85% of mRNA molecules in the cytoplasm and in the whole cell, nuclear RNA populations are more diverse. The nucleus is particularly enriched for functional non-coding RNAs such as snoRNA, and for isoforms with a retained intron (10 to 20% of the nuclear RNA fraction). Finally, as expected, pre-mRNA represents less than 3% of the cytoplasmic RNA fraction.

In light of our results, we conclude that our method of fractionating liver cells performed as expected, and that our analysis of RNA distribution in the nucleus and cytoplasm supports previous findings [36,30].

Static relationships between levels of successive RNA species and dependencies on cytoplasmic RNA stability, nuclear export and splicing rates

Before analysing temporal aspects of these datasets, we first studied the relationships between the temporal averages of the various RNA species, in particular properties related to cytoplasmic RNA stability, nuclear export, and splicing.

First, we compared nuclear (NAE) and cytoplasmic (CAE) polyadenylated mRNAs. As noted in a previous study [4], in the simplest scenario where there is no degradation in the nucleus, the steady-state ratio of NAE over CAE reflects the ratio of two parameters: the nuclear export rate and the cytoplasmic degradation rate (Fig 1B). A fast export from the nucleus to the cytoplasm would deplete the amount of RNA in the nucleus, and a long cytoplasmic half-life in the cytoplasm would lead to an accumulation of mRNA in the cytoplasm. On the contrary, RNAs with a long export time (or long nuclear retention) and short half-life in the cytoplasm would increase the nuclear to cytoplasmic ratio, resulting in an apparent nuclear accumulation.

Across all genes, the expression levels of NAE span 8.8 log2 RPKM (102.6 fold). CAE has a wider distribution of expression level of 12.5 log2 RPKM (about 104 fold, Fig 2A). The most abundant transcripts code for secreted proteins such as Murine Urinary Proteins, Albumin, and Apolipoproteins, and are enriched in the cytoplasm. The NAE/CAE ratio varies by a factor of almost 2500, with a median log2(NAE/CAE) around -2.3, indicating that RNA transcript counts are more abundant in the cytoplasm than in the nucleus. The nuclear-enriched RNA population includes the long non-coding RNAs Malat1 and Neat1, which form the backbones of nuclear speckles and nuclear paraspeckles [31,32]. Moreover, a fraction of transcripts are also found enriched in the nucleus, consistently with a previous study [4] showing that in the mouse liver, protein coding genes such as Nlrp6 (here log2-ratio = 1.6), and glucose metabolism-related genes Mlxipl (log2(NAE/CAE) = 3.4), and Gcgr (log2(NAE/CAE) = -0.1) were indeed enriched in the nucleus.

Fig 2. The ratio of nuclear and cytoplasmic mRNA abundance is related to transcript length.

Fig 2

A: Expression level of nuclear mRNA (NAE) versus cytoplasmic mRNA (CAE) in log2(RPKM), averaged over 6 time-points and 12 animals. In our model, the level of NAE corresponds to the transcription rate plus the nuclear half-life, and the level of CAE to the transcription rate plus cytoplasmic half-life (all in log2-scale). Cyan squares represent known nuclear genes and magenta squares cytoplasmic genes [4]. Dashed line indicates the 1:1 ratio. Note here that the diagonal line has been scaled with the dataset (see Methods). Grey contour lines: 2D kernel density estimation. Number of genes = 10914. B: Log2-ratio of NAE / CAE against the average expression in the cytoplasm in log2-scale (up) or in the nucleus (bottom). C: smFISH of the Mlxipl and Actb transcripts in liver FFPE sections, at ZT12. Nuclei are stained with DAPI (grey). D: GO Terms enrichment analysis of nuclear and cytoplasmic protein coding genes. Left: All the genes belonging to the nuclear enriched GO Terms are highlighted in color: histone modifications (GO:0016570, GO:0033169, GO:0070076, GO:0006306, and GO:0044728), mRNA export (GO:0010793, GO:0010793), and splicing (GO:0006376, GO:0043484). Right: all the genes belonging to some of the cytoplasmic enriched GO Terms are highlighted in color: Cellular respiration (GO:0042775, GO:0022904, GO:0015986, GO:0006123), and Translation (GO:0006412, GO:0002181, GO:0006414,). E, F, G, H: log2(NAE/CAE) ratio against the following genomic features: 5’UTR length and 3’UTR length (E), transcript length (spliced isoform, F, G) and gene length (exon + intron, H). To simplify, these transcript-specific features were averaged (weighted) based on the expression levels of each transcript to obtain a value per gene (E, F, H) or per biotype (G). Grey dashed line is the regression line.

In our simplified model, the steady-state log2(NAE) = log2(Transcription rate) + log2(export time), and log2(CAE) = log2(Transcription rate) + log2(half-life). Note here that our system is underdetermined, and that times / rates discussed here are relative. The fact that log2(NAE) and log2(CAE) strongly co-vary, and that the transcription rate is added to both, implies that this process carries the largest variation, as expected. We next aimed to determine which molecular process co-varied most with the NAE/CAE ratio. The strong correlation coefficient with NAE and absence of correlation with CAE suggests that the cytoplasmic half-life has a higher influence on the ratio than the export time (Fig 2B). We verified the subcellular localisation of a known nuclear-biased transcript (Mlxipl) by smFISH, and its nuclear accumulation was evident, although not precisely quantifiable due to its high abundance and crowdedness of mRNA molecules (Fig 2C). On the opposite side, Actb is a typical example of a cytoplasmically enriched transcript (log2(NAE/CAE) = -3.64), which was verified by smFISH, showing a log2(NAE/CAE) that varied between time points, ranging from -1.42 to -3.8, with a median of -2.7.

To identify the biological functions of nuclear and cytoplasmic-enriched RNA populations, we performed an ontology gene set functional analysis on nuclear and cytoplasmic-biased protein coding genes. We found that transcripts coding for histone modifiers and mRNA processing (splicing and export) are enriched in the nucleus, while proteins encoded by cytoplasmic-enriched RNA were involved in translation and ribosome biogenesis, cellular respiration, sterol metabolism (Fig 2D and S4 Table).

We next examined several genomic features that may modulate kinetics (transcription rate, export, decay) and as a consequence mRNA localisation, such as gene length, transcript length, number of exons, 3’UTR and 5’UTR length [6,30,33]. The 3’UTR length (but not the 5’UTR length) showed a positive correlation with the nuclear to cytoplasmic ratio (R2 = 0.16), indicating that transcripts with longer 3’UTR sequences are enriched in the nucleus (Fig 2E). The length of the 3’UTR is often proposed as a predictor of mRNA stability, because of the presence of many regulatory elements. However, both stabilising and destabilising RNA-Binding Proteins and miRNAs often compete for the same mRNA substrate [34], which in the end results in a conflicting or undetectable effect of the 3’UTR length on processing rates [6]. Strikingly, we found that spliced transcript length (corresponding to the total exon length) has a significant positive correlation with nuclear localisation (R2 = 0.31, Fig 2F), and the correlation is improved when focusing only on protein coding transcripts (Fig 2G, R2 = 0.41). As transcripts of hundreds of kilobases take several hours to be fully transcribed [35], this could explain the longer residence time in the nucleus. However, in that case, we would expect a correlation with gene length as well, which was not observed (Fig 2H), suggesting that the structure of the mature mRNA rather than transcription plays a role in the differential localisation.

We next performed an analogous analysis to compare nuclear pre-mRNAs and nuclear polyadenylated mRNAs, estimated from NTI, and NAE, respectively (S1 Fig). We found a strong correlation between NTI and NAE (S1A Fig, R2 = 0.6), suggesting that transcription rate, the common factor to both NTI and NAE (log2(NTI) = log2(Transcription rate) + log2(splicing and polyadenylation time), and similarly for NAE), has a larger effect on NTI and NAE levels than export and splicing rates. The fact that the correlation is stronger here than for log2(NAE/CAE) (R2 = 0.60 vs. R2 = 0.47) suggests that the variability (across all genes) in splicing times is smaller than that of cytoplasmic life times. Here, we found that log2(NTI/NAE) is more correlated with the export time (NAE) than with the splicing time (NTI) (S1 Fig, R2 = 0.28 for NAE, R2 = 0.015 for NTI). This observation suggests that, on average, the abundance of spliced nuclear mRNA (NAE) is more strongly determined by the variation of nuclear export time rather than splicing time of the pre-mRNA. However, transcription, splicing and export are not always independent processes and can be coupled and thus, the interpretation of the correlations may be more complicated [3638].

The extent of co- versus post-transcriptional splicing increases with gene length

In case of complete co-transcriptional splicing, Nuclear Total pre-mRNA (NTI) represents the population of nascent transcripts [22,39,40]. However, in Fig 1D, we observed that approximately 12% of the nuclear polyadenylated transcriptome encoding for proteins are pre-mRNA (captured in NAI samples), suggesting that a fraction of pre-mRNA is spliced post-transcriptionally. To estimate the amount of co- and post-transcriptional splicing, we compared the levels of NTI to NAI of genes belonging to the Protein Coding biotype (S2 Table). When the expression level of NAI is close to NTI, most of the nuclear pre-mRNA are fully transcribed and polyadenylated before being spliced. Conversely, a higher level of NTI compared to NAI means that nascent pre-mRNAs make up most of NTI and introns are spliced co-transcriptionally. Co-transcriptional splicing creates a typical sawtooth pattern of decreasing density of reads mapping on intron, with higher signal toward the 5′-end, described in nascent-seq datasets [23,41]. We indeed visually observed the sawtooth patterns on genes such as Egfr or Zhx2 (Fig 3B), while these were absent on transcripts on the identity line (NAI = NTI), such as Gstm6 or Apol7a (Fig 3C). Using the NAI/NTI ratio as proxy of co- versus post-transcriptional splicing, we observed a striking correlation of the ratio with the gene length, such that transcripts originating from a long gene sequence are more likely co-transcriptionally spliced, while short genes are more often post-transcriptionally spliced. Note that here we did not consider gene structure or the ordering of the introns. This length-dependency may reflect the situation where transcription and 3’ end processing is already terminated by the time the spliceosome assembles and splices newly transcribed introns. If splicing and transcription are two processes occurring concurrently but without further dependency, the longer the gene, and particularly the longer the downstream exon, the higher the probability for the upstream intron to be detected and spliced. NTI alone, representing the total pool of pre-mRNA in the nucleus, is not influenced by the gene length (Fig 3D). The comparison of the levels of nuclear pre-mRNA in both Total and Poly(A) conditions is therefore informative about the extent of co- vs post-transcriptional splicing, which is strongly influenced by gene length.

Fig 3. The extent of co- versus post-transcriptional splicing increases with gene length.

Fig 3

A: Comparison of pre-mRNA expression levels in Poly(A) et Total nuclear RNA populations of protein coding transcripts (grouped by biotype): log2(NTI) against log2(NAI). Transcripts on the identity line (NAI = NTI, dashed line) are not spliced co-transcriptionally, while those away from the line are. Genes whose genome track are shown in B and C are shown on the plot. Red: 2D kernel density. Only protein coding transcripts are shown. B: Genome track view of short genes that are mainly post-transcriptionally spliced. Gene length of Gstm6: 4.9kb, Apol7a: 11kb. C: Genome track view of long genes that are mainly co-transcriptionally spliced. Gene length of Zhx2: 145kb, Egfr: 166 kb. Genome tracks are not to scale. D: Correlations of the gene length (exon + intron) with log2(NAI), log2(NTI) and log2(NTI/NAI). The latter is related to the fraction of co- and post-transcriptional splicing. Overall, long genes are more frequently co-transcriptionally spliced than short genes.

Model-based identification of regulatory steps driving rhythmic cytoplasmic mRNA profiles

The accumulation of RNA transcripts in any of the subcellular compartments results from the balance between production and elimination. At steady-state (Figs 2 and S1), it was generally not possible to identify the two respective contributions. However, as we showed before, it is possible to determine these rates from time-series profiles when genes are rhythmic, using a mathematical modelling approach [12]. In essence, by modelling the profiles of causally related and oscillating RNA species, for example intronic and exonic reads from total unfractionated RNA-seq, the approach can infer production and degradation rates. We applied this method to two situations. First, a joint model of mRNA accumulation in the cytoplasm (CAE) and the nucleus (NAE) allowed us to estimate the cytoplasmic stability and assess rhythmic degradation processes (hereafter referred to as step 2, Fig 4A). Using the fractionated cell data, we now can specifically address cytoplasmic half-life instead of estimate an effective half-life that encompasses all intermediate processes occurring in the nucleus [12]. Next, we modelled the expression profiles of nuclear mRNA (NAE), which increases due to splicing of pre-mRNA (NTI) and decreases due to nuclear export (step 1). This strategy allowed us to infer the nuclear export rates and to uncover rhythmically regulated exports. Each step is described by an ordinary differential equation, where the first variable (NTI in step 1, NAE in step 2) and the rate of degradation (export e in step 1, cytoplasmic degradation γ in step 2) are either constant or rhythmic (defined by a cosine function with a phase and relative amplitude). The combination of constant or rhythmic production and degradation terms generates four different kinetic models (M1 to M4, Fig 4B). The optimal model is selected by combining a maximum-likelihood approach with the Bayesian information criterion (BIC) to control for model complexity. For genes with constant levels of pre-mRNA and mRNA (M1), only the ratio between the production and degradation can be determined. Note that this approach is different from rhythmicity assessment on one condition and has been previously applied to genotype comparisons [16]. We first applied the mathematical model to step 2 (NAE-CAE) to identify rhythmic cytoplasmic half-lives (S5 Table). Out of the approximately 11,000 genes expressed in the liver, we confidently classified 1,424 genes as having a rhythmic accumulation of nuclear RNA (M2 and M4), of which 79 are additionally rhythmically degraded (M4, Fig 4D). The rhythmic profiles of 386 genes in the cytoplasm are solely due to the temporal regulation of the cytoplasmic half-life (M3). Thus, approximately 15% of expressed genes have a rhythmic temporal profile in at least one cellular compartment. Additionally, 25% are degraded rhythmically, similar to previous studies in the mouse liver (28% in [12], 30% in [11]). The median half-lives are 2.45 h for M2, 3.88 h for M3 and 2.36 h for M4.

Fig 4. Model-based identification of regulatory steps driving rhythmic cytoplasmic mRNA profiles.

Fig 4

A: Kinetic model describing the temporal accumulation of pre-mRNA and mRNA. RNA processing steps are split in two steps: first, we describe the temporal accumulation of nuclear mRNA (NAE) in function of splicing rate s and export rate e (step 1), and second, the temporal accumulation of cytoplasmic mRNA (CAE) in function of export rate e and degradation rate γ (step 2). B: The combination of constant or rhythmic pre-mRNA (p) and constant or rhythmic export in step 1 generates four models. Rhythmic pre-mRNA profile is described by a cosine function with a period of 24 hours, raised to a power β to account for the peaked oscillatory profiles. The same equations apply to step 2, but with γ instead of e, m instead of p, and M instead of m. C: Classification of genes in step 2: M2 (rhythmic NAE, constant degradation), M3 (constant NAE, rhythmic degradation), or M4 (rhythmic NAE, rhythmic degradation). D: Distribution of estimated cytoplasmic half-lives. To facilitate identification and considering biologically plausible ranges, we set the range of possible half-lives from 10 min to 24 h. During the optimization, γ = log(2)/half-life sometimes reaches our fixed upper limits or lower limits. The median half-life (dotted line) is calculated excluding half-lives reaching the lower or upper boundary. E: Circular histogram showing the phases (peak times) of CAE in each model. F: Representative temporal profiles (NAE and CAE) of genes in M2, M3 and M4 genes with short half-life (up) or long half-life (bottom). Values on top of the plots indicate the half-life of the gene. In M3 and M4, mean half-lives with their corresponding min and max are indicated.

The distribution of peak mRNA times in the cytoplasm differs between the models. While M2 peak times were homogeneously distributed throughout the day, M3 exhibited a biphasic phase pattern with distinct associated biological functions. M3 genes peaking between ZT3 and ZT9 are involved in protein degradation such as proteasome components Psmd3, Psmf1, Adrm1. A second group of M3 associated genes peak between ZT14 and ZT18. This group comprises genes related to nuclear mRNA processing such as Sfpq and Cpsf6, and the splicing factors Srsf1, Srsf3, Sfpq, or Thoc7, Hnrnpa3 and Hnrnph1.

In Fig 4F, we show representative genes to illustrate the typical behaviour of each model. When degradation is constant (M2), the more stable is the transcript, the more the mRNA oscillations dampen, and the longer the peak time difference between NAE and CAE. Note that in this model, this time delay cannot exceed 6 hours (it reaches 6 hours for infinitely long half-lives [25]). Transcripts with a short half-life have similar peak times (no delay) and relative amplitudes in the nucleus and in the cytoplasm (Fig 4F). Genes classified in M3 are rhythmic only in the cytoplasm. Fus is a well-known example of a gene rhythmically regulated at the post-transcriptional level [12,25]. Finally, genes in M4 are rhythmically regulated both at the transcription and degradation level, resulting in more complex patterns, for instance a higher relative amplitude in the cytoplasm (Ddo, half-life 7 h) or a longer time delay (Cbs, half-life 1.4 h).

Kinetic model identifies rhythmically exported nuclear mRNAs

To uncover potentially rhythmic patterns generated by rhythmic nuclear export, we next applied the mathematical model to compare the rhythmic profiles of nuclear pre-mRNA (NTI) and nuclear mRNA (NAE) (S5 Table). Here, the export time refers to the time spent by a fully transcribed, spliced, and polyadenylated transcript in the nucleus. We confidently classified 1632 genes in one of the three models with rhythmic NAE (Fig 5A). The vast majority were rhythmically transcribed and exported with a constant rate (1428 genes as M2). 13% were exported rhythmically (M3 and M4), suggesting that nuclear export is a post-transcriptional mechanism contributing to modulation and generation of rhythmic profiles. Representative profiles of genes classified as M3, whose rhythmic nuclear mRNA accumulations were only attributed to rhythmic mRNA export, are shown in S2 Fig. Proteins encoded by these genes cover a diverse biological functions, such as deacetylation (Lypla2, Sirt5), nuclear speckles assembly and splicing (Srrm2, Akap8l), hypermethylation of sn(o)RNA m7G cap (Tgs1), or NAD(P)H-dependent oxidoreduction (Rdh13). Rhythmic export generated nuclear rhythms that propagated to the cytoplasm (S2 Fig). However, the median log2 fold-change of CAE (cytoplasmic mRNA) is lower than those originating from M2 or M4 genes (Fig 5E), but is still near 1 (2-fold amplitude). While some oscillations are damped in the cytoplasm because of the long stability of cytoplasmic mRNA, others keep oscillating with relatively large amplitudes.

Fig 5. Kinetic model identifies rhythmically exported nuclear mRNAs.

Fig 5

A: Classification of genes in M2 (rhythmic transcription, constant export), M3 genes (constant transcription, rhythmic export), or M4 (rhythmic transcription, rhythmic export). B: Distribution of estimated export times of the three models. The median (dotted line) is calculated excluding export times reaching the lower or upper boundary (5 min and 12 h). C: Distribution of peak times of rhythmic nuclear mRNA (NAE). C: Distribution of peak time of rhythmic export rates (shortest export time) of M3 and M4 (in M2, export is constant). D: Representative temporal profiles of nuclear pre-mRNA (NTI) and nuclear polyadenylated mRNA (NAE) in M2, M3 and M4 genes with short export time (up) or long export time (bottom). Additional examples of M3 genes are shown in S2 Fig. E: Cytoplasmic mRNA fold-change of genes classified as M2, M3 or M3 in step1. F: distribution of phases in the cytoplasm of genes classified as M2, M3 or M4 at step 1.

The distribution of NAE peak times in M3 genes showed an enrichment around ZT8 (Fig 5C, 33% of the M3 genes peak in the time window between ZT6 and ZT10). By contrast, peak times of M2 genes, whose rhythms are generated by rhythmic transcription, exhibited the typical bimodal distribution of phases peaking at the end of the light phase (ZT22) and the dark phase (ZT10), reflecting the two waves of transcriptional activity in the liver [25,42,43]. Phases of M4 genes, whose nuclear accumulation is also regulated by rhythmic export, were distributed throughout the day. The time of shortest export time (highest export rate) was enriched in the second part of the night (half of the M4 genes had the highest export rate between ZT18 to ZT 0). The difference between the peak time of export rate and peak of transcription rate modulates the resulting pattern of NAE: rhythmic amplitudes of carbohydrate and lipid metabolism transcripts such as Pck1, Lpin1 or Ppard are amplified by antiphasic rhythmic export, while genes such as Sqle or Lipc are damped while maintaining a phase coherence because export peak time matches transcription peak time (Fig 5D). Thus, the amplitudes of several key metabolic enzymes were boosted by a timed export process.

Nuclear residence times are known to be typically shorter compared to cytoplasmic half-lives. Indeed, previous studies estimated that nuclear lifetime ranges from 5 min to less than a couple of hours (maximal estimated nuclear residence time: 40 min in [44], 90 min in [45], 2 h in [4]). In our model of step 1, we set the range of possible export times from 5 min to 12 h. More than one third of the genes in our dataset reaches the lower boundary of 5 min (600 genes), suggesting that indeed, rhythmic transcripts are usually exported on a short time scale. The median export time, if we include those genes, is 25 min for M2 and M3 genes, and 12 min for M4 genes. Even if the majority of transcripts were processed and exported within minutes, some mRNA resided for several hours in the nucleus. For example, genes involved in steroid biosynthesis such as Srd5a1, Hsd17b2, Dhcr7, and Scap, have an estimated nuclear half-life between 2 h and 3.5 h. However, major regulators of cholesterol synthesis are exported rapidly from the nucleus (Insig1, Cyp7a1, Hmgcr, export time of 5 min). This suggests that despite being rhythmically transcribed, biologically related genes have distincts dynamic patterns in the nucleus. Genes involved in fructose metabolism were also enriched among long-lived transcripts (Aldob: 6,8 h, Khk: 4.8 h, Sord: 1.4 h, Fbp1: 6 h). It is noteworthy that nuclear retained mRNAs include the glucokinase regulatory protein Gckr (3.2 h), genes related to thyroid hormone metabolite (Dio1: 2.5 h, Thrsp: 1.4 h) and related to glyoxylate metabolism (Agxt: 1.8 h, Grhpr: 1.9 h).

Circadian core clock and PARbZip genes are enriched in the nucleus

Finally, we focus on the temporal behavior of core clock and PARbZip family member clock output genes. Cytoplasmic mRNA half-lives of all such genes were below 2.5 h, and nuclear half-lives ranged from 5 min to 1.1 h, allowing an efficient propagation of high-amplitude patterns (Fig 6A and 6B). Note that Dbp and Rev-Erbα (Nr1d1) were classified as both rhythmically exported and rhythmically degraded, which explains their particularly high relative amplitudes. As a consequence of their high cytoplasmic degradation rates, clock genes were more enriched in the nucleus compared to all cycling genes. Of interest, all three Period mRNAs (Per1, Per2, Per3) were particularly enriched in the nucleus, despite having similarly short half-lives compared to the other core clock genes, suggesting that these could be potentially slowly exported (Fig 6C). We verified by smFISH the subcellular localisation of Per1 together with another core clock gene Bmal1 (also named Arntl) on the same liver samples used for the RNA-seq (Fig 6C). Quantification of nuclear and cytoplasmic mRNA in situ at peak and trough expression confirmed that the nuclear-to-cytoplasmic ratio of Per1 (1:1 at ZT12) is more nuclear than the ratio of Bmal1 (1.6 times more cytoplasmic mRNA at ZT0). Cry1, another core clock gene, showed a similar nuclear-to-cytoplasmic ratio in both RNA-seq and smFISH as Arntl (1.5 times more cytoplasmic mRNA at ZT20, Fig 6E and 6F).

Fig 6. Circadian core clock and PARbZip genes.

Fig 6

A: RNA-seq temporal profiles of clock genes and clock-controlled genes (PARbZip family members), sorted by their nuclear-to-cytoplasmic ratio. B: log2(NAE/CAE) versus cytoplasmic half-life estimated at step 2. Dashed vertical line represents the median half-life times of all rhythmic mRNAs. Dotted horizontal line represents the median log2(NAE/CAE) ratio of all rhythmic mRNAs. C and E: smFISH of core clock mRNAs Per1, Arntl, and Cry1 at their maximal and minimal expression levels in mouse liver tissue. Nuclei stained with DAPI (blue). Scale bar: 10μm. 63x magnification. D and F: Quantification of nuclear and cytoplasmic mRNA transcripts on smFISH images. The nuclear-to-cytoplasmic ratio of Per1 is significantly more nuclear than Arntl and Cry1 at their respective peak time (pairwise t-test, Bonferroni correction, p-value < 10−5) and < 10−4 respectively). 4–6 images were taken per animal, with each field of view containing on average 500 nuclei. The average number of mRNA molecules per number of nuclei in each image is represented (dots). Number of nuclei analysed: Arntl and Per1: 3237 (ZT0), 3300 (ZT12). Cry1: 1714 (ZT8) and 1319 (ZT20).

Discussion

Gene expression is a highly regulated multistep process. We produced time series RNA measurements from fractionated liver cells to feed a simplified model, including rhythmically regulated nuclear export and cytoplasmic degradation. Cellular fractionation first allowed us to highlight characteristics and differences of the nuclear and cytoplasmic transcriptomes. Notably, at steady-state, we observed a previously reported concordance between protein and RNA localisation [30]: nuclear enriched mRNAs mainly code for nuclear regulatory proteins, and could be unstable as a way to facilitate rapid adaptation of protein production in response to external stimuli [34]. Additionally, since nuclear retention acts as a passive filter reducing transcriptional noise [4547], retaining these transcripts could allow a stable production of proteins. On the other hand, transcripts enriched in the cytoplasm mainly code for proteins involved in house-keeping functions such as respiration and translation, presumably due to their increased stability [10,48]. Another difference between nuclear and cytoplasmic mRNAs is related to their length. Long transcripts were enriched in the nucleus, while short transcripts were more abundant in the cytoplasm. This asymmetric distribution could be again related to the cytoplasmic mRNA stability. Although our observations were made only on mouse liver tissue, a link between transcript length and decay rate was hinted at in Drosophila Kc167 cells [6]. Since mRNA degradation that occurs through the deadenylation of the poly(A) tail and a subsequent exonuclease attack [34] has not been linked with transcript length, the higher instability of long transcripts may reflect an increased probability to be stochastically attacked by endonucleases [6].

Another process that depends on genomic length is splicing. Splicing mainly occurs co-transcriptionally in most organisms [41,4951]. However, the proportion of introns that are removed concurrently with transcription is still under debate, and is highly variable depending on the organism and experimental methods [52]. For example, pre-mRNAs in mouse liver are less frequently spliced co-transcriptionally compared to Drosophila [53]. We investigated the proportion of co- versus post-transcriptionally spliced genes by comparing the expression level of intronic signals in nuclear total pre-mRNA (NTI) and the nuclear polyadenylated pre-mRNA (NAI). We noticed a strong correlation with gene length, namely, long pre-mRNA showed more frequent co-transcriptional splicing compared to shorter pre-mRNAs. Similar observations on the dependency of gene length and splicing regime were found in a previously published dataset in mouse embryonic stem cells, where longer introns were more likely removed post-transcriptionally [54]. Our observations thus support that when a gene is short, transcription is already completed by the time the intron is recognised and spliced. If the gene is long, the spliceosome has more time to recognise splice sites, assemble on the pre-mRNA, and cleave the intron. This relationship with gene length was stronger when focussing on protein coding transcripts only, which could reflect the different processing mechanisms regulating distinct classes of RNAs [1]. It is also known, however, that transcription and splicing can be coupled through physical interactions of the associated protein machineries, which can also be favoured when these factors are concentrated in one location, such as in nuclear speckles and paraspeckles [55]. Such coordination of transcription and splicing processes also modulates alternative splicing events [56], which was not specifically assessed in this work. Indeed, for simplicity and due to technical limitations of obtaining sufficiently accurate isoform-specific expression levels, we have summarised our results at the gene level by weighting the isoforms by their estimated expression levels. We also did not consider variations in splicing efficiencies of introns within a gene body, which differ depending on the length of the downstream exon or on whether flanking exons are alternatively or constitutively spliced [3,51,57]. In the future, more sophisticated methods such as long-read sequencing would be necessary to refine the splicing models [58]. Indeed, while being highly promising, long-read sequencing technologies are currently limited in the length of sequenced transcripts (15kb to 30 kb) and are still biased toward short length transcripts [59].

We next investigated the temporal dimension of our dataset to identify possible new layers of circadian gene regulation, in addition to the many mechanisms mentioned in the introduction, notably chromatin states, transcription, alternative splicing, translation, protein accumulation and localization (reviewed in [60]). We adapted our previously developed models that take advantage of the relationship between relative peak times and relative amplitudes describing the propagation of oscillations to estimate the cytoplasmic degradation rates and nuclear export rates of approximately 1400 genes. These differential equations models describe the lifecycle of an RNA transcript, for example the nuclear pre-mRNA (NTI) is transformed into mRNA (NAE) through an effective splicing rate that combines the splicing rate of the individual introns, and which is then exported at a given rate. These are clearly highly simplified views of the complex processes, and it also remains challenging to infer those parameters from the data fits. Notably, the splicing time is identifiable only for some of the models where we have set a prior on it, in other models (e.g. static) only a relative splicing time can be obtained (Methods). Further experimental validations would be needed to assess the accuracy of the predicted splicing times. With those models, we found a median cytoplasmic half-life of 2.5 h for cycling transcripts. In general, mRNA half-lives range from minutes to several hours, and the estimation varies depending on the model (cell type, tissue) and method (total RNA-seq, transcription inhibition, metabolic labelling). As a comparison, median half-lives of mRNA was 9 h in NIH3T3 cells [8], 3.9 h in mouse ESCs [61], 4 h in HEK293 cells [62] 3.4 h in HELA cells [48], and 2.1 h in another study with NIH3T3 fibroblasts [63]. Our shorter estimations can be explained by our focus on rhythmic genes, which need to be relatively short-lived to maintain oscillations. We also estimated that 25% of mRNA in the cytoplasm are degraded cyclically, which offers flexibility to boost amplitudes and fine-tune phases [11, 12, 25, 64]. Such fluctuations of mRNA stability can occur through the activity of plethora of RNA-binding proteins [6567], through silencing by miRNA [68], by regulating poly(A) tail length [69], and regulating deadenylase activity [70].

Nuclear export times are overall shorter and the majority of the rhythmic nuclear mRNA have a half-life of less than 25 min. Our experimental design reliably detects long export times on the order of our sampling time (in the range of hours), but does not allow a precise quantification of processes happening at extremely short time-scales. For a majority of genes, ignoring the nuclear export step as we and others previously did [11,12] is a valid assumption due to its small contribution to the total mRNA lifetime. However, when nuclear lifetime significantly contributes to the total RNA lifetime, our dataset allows us to separate the processes and provide a more specific interpretation of the kinetic processes. In addition, we were able to uncover rhythmic patterns in the nucleus, which strongly suggests that the nuclear lifetime varies around the day for 12.5% of the rhythmic nuclear mRNA. As a result, amplitudes of several rhythmically exported mRNA such as Pck1, Por and Lpin1 involved in liver metabolism were boosted. Rhythmic export could be modulated by nuclear RNA processing factors. For example, the components of nuclear paraspeckles NONO and SFPQ, display rhythmic nuclear accumulation profiles in mouse liver cells [26]. Interestingly, NONO binds around a thousand mRNA in the liver, of which about one third exhibits circadian accumulation [29]. The deletion of NONO in a knock-out mouse model altered the rhythmic profiles of hundreds of mRNA profiles (but not systematically of the pre-mRNAs) by advancing or delaying the phase, or abolishing the rhythm, suggesting a pleiotropic role of NONO in the post-transcriptional regulation of rhythmic nuclear mRNA accumulation. The role of paraspeckles in regulating rhythmic export was established by transfecting a reporter mRNA with an IRAlu element fused in its 3’UTR in rat pituitary cell line, which was retained in the nucleus and released in the cytoplasm in the circadian manner [71]. Thus, nuclear export is most likely one of the many regulatory layers of rhythmic gene expression in mammalian cells.

The temporal analysis of our dataset was performed only at the whole gene-level and we therefore did not look into differential rhythmicity of splice isoforms. In previous works on circadian alternative splicing, it was found that mRNAs encoding for splicing-related genes frequently exhibited 24-h rhythmic expression with a bimodal distribution of peak phases across tissues and species, indicating that they might be controlled by the circadian clock [72,73]. Concomitantly, rhythmic alternative splicing was found to be widespread across mammalian tissues and conserved alternative splice isoforms that peaked at opposite times of the day were reported in oncogenes and tumour suppressors [73]. In the liver, it was reported that the feeding/fasting cycle modulates hepatic circadian alternative splicing in an exon-dependent manner [74]. In general, there is a risk that some circadian regulation will be masked with gene-level analyses. Nevertheless, inference of alternative transcript isoforms remains challenging with short read sequencing [59], and stratifying the analysis of the half-lives by transcript isoforms would make our dynamical models too complex. Advances in long-read sequencing technologies would allow refined isoform-levels dynamic transcriptome analysis, contributing to a better understanding in physiological or pathological conditions [73].

In this work, we provided a comprehensive and temporal inventory of RNA nuclear and cytoplasmic localisation in mouse livers, as well as an identification of the nuclear or cytoplasmic origins of transcript rhythms. In particular, this analysis suggests that mRNA oscillations can be post-transcriptionally modulated also at the level of nuclear export, and contributes to a better understanding of the dynamic regulation of the transcriptome over the 24 hours day.

Methods

Ethics statement

All animal care and handling were approved by the Canton de Vaud laws for animal protection (authorisation VD.3197).

Animal housing and mouse liver sampling

All mice experiments were performed on male WT mice (C57/BL6J) aged from 8 to 12 weeks old, and housed in 12:12 light:dark cycle. 3 days prior to sacrifice and sampling day, mice were given access to food only during the active phase (night-restricted feeding). Two mice were sacrificed by decapitation every 4 hours (ZT0, 4, 8, 12, 16 and 20). ZT0 is the beginning of the light phase, and ZT12 is the beginning of the dark phase. Pieces of liver were immediately collected after sacrifice for RNA extraction and histological analysis (single-molecule RNA-FISH).

Cellular fractionation and RNA extraction

Nuclear and cytoplasmic liver mRNA were isolated according to the Nascent-seq protocol [23] with few modifications. Briefly, approximately 300mg of the big lobe were homogenised with a Potter-elvehjem PTFE pestle (DWK Life Sciences #9651693, Aesch, Switzerland) together with 3.5ml of ice-cold PBS (Thermo Fisher Scientific #AM9625, Waltham, USA) and 3.5ml of homogenisation buffer (2.2M sucrose (Sigma Aldrich #84097, St. Louis, USA)), 15mM KCl (Sigma-Aldrich, #P9541), 2mM EDTA (Thermo Fisher Scientific #AM9261, 10mM Hepes pH 7.6 (Sigma-Aldrich #J61047), 0.15 mM spermine (Sigma-Aldrich #S1141), 0.5mM spermidine (Sigma-Aldrich #S2626), 0.5 mM PMSF (Sigma-Aldrich #329-98-6), 1mM DTT (Thermo Fisher Scientific #R0861), 20 μg/ml aprotinin (AppliChem #A2132, Darmstadt, Germany), 2.5μg/ml leupeptin (Sigma-Aldrich #L2884), 100μg/ml pepstatin (AppliChem #A2205), and 10U/ml RNAseOUT RNase inhibitor (Invitrogen #10777019, Carlsbad, USA)). The homogenate was mixed with the remaining homogenisation buffer (total volume of homogenisation buffer: 18ml) and layered on top of 7.2ml of a sucrose cushion buffer (2.05 M sucrose, 10% glycerol, 15mM KCl, 2mM EDTA, 10mM Hepes pH 7.6, 0.15 mM spermine, 0.5 mM spermidine, 20 μg/ml aprotinin, 2.5 μg/ml leupeptin, 100 μg/ml pepstatin, 0.5 mM PMSF, 0.1 M DTT, 10 U/ml RNAseOUT RNase inhibitor). The liver homogenate was ultra-centrifuged in a SW28 rotor (Beckman Coulter #342207, Brea, USA) at a speed of 103’000 g, at 4C° for 1 hour. Supernatant (cytoplasmic fraction) was mixed with ethanol (final ethanol concentration of 70%) and stored overnight at -80°C. Cytoplasmic extracts in ethanol were centrifuged at 5000 rpm for 15 min at 4°C to precipitate RNA. Ethanol was discarded, and the pellet was resuspended in 800ul of QIAzol Lysis reagent (QIAGEN #79306, Venlo, Netherlands). RNA was extracted on spin columns using the miRNeasy Kit (QIAGEN #74104) according to the manufacturer’s instructions. After ultracentrifugation, the pellet (nuclei) was resuspended in 3ml of Nuclear RNA extraction buffer (guanidium thiocyanate 50% (w/v) (Sigma-Aldrich #G9277), sodium citrate 0.75M pH7 (Sigma-Aldrich #1613859), 200μM sodium acetate 2M pH 4 (Sigma-Aldrich #71180) and 1% β-mercaptoethanol (Sigma-Aldrich #M6250)), and was mechanically homogenized through a syringe needle 26G. 3ml of water-saturated phenol pH 4.5 (Fisher Scientific #802517) and 1200μl of chloroform:isoamyl alcohol 24:1 (Sigma-Aldrich #25666) were added to the resuspended pellet, and were well shaken before resting for 15 min at room temperature. The mix was centrifuged at 4°C at 1500g for 20 min. The supernatant was resuspended in ethanol (final volume 60% (v/v)). RNA is then extracted on spin columns using miRNEasy kit according to manufacturer’s instructions, including a DNAse treatment (QIAGEN #79254, Venlo, Netherlands).

For total liver RNA extraction, pieces from the main liver lobes were frozen in liquid nitrogen. About 20mg were frozen and used for RNA extraction using the miRNEAsy kit.

RNA-sequencing

To sequence polyadenylated nuclear and cytoplasmic RNA, we used the TruSeq stranded mRNA LT kit (Illumina #20020594, San Diego, USA), starting from 650 ng of RNA, according to the manufacturer’s protocol. To sequence total RNA (with ribosomal RNA depletion), we used the KAPA RNA HyperPrep Kit (Kapa Biosystems #KK8540, Wilmington, USA) with RiboErase prep (Kapa Biosystems #KK8560, Wilmington, USA) combined with KAPA Unique Dual-Indexed Adapter Kit Illumina Platforms (Kapa Biosystems #KR1736, Wilmington, USA), starting from 650 ng RNA. Libraries were sequenced on a Hiseq4000 (Illumina, San Diego, USA). We used a SBS 50 cycles and SR cluster kit, performing a single read sequencing of 65 nucleotides. We sequenced on average 70M reads for Nuclear PolyA and Nuclear Total samples, 25M reads for Cytoplasmic PolyA and Cytoplasmic Total samples, and 50M reads for the Unfractionated samples.

Quantification of pre-mRNA and mRNA expression levels was performed using Kallisto version 0.46.0 [28]. A combined index was built using reference fasta files from Ensembl for mus musculus (GRCm38). In particular, pre-mRNA (introns and exons) and mRNA (exons) reference sequences were used as an input and named accordingly. Additionally, we had added spike-in mRNA originating from rat liver (male Wistar, donated by the Laboratory for Functional and Metabolic Imaging, EPFL) accounting for 5% of the total mass liver, but these were in the end not used. Therefore, the reference genome used for the mapping includes fasta files from rattus norvegicus (Rnor_6.0). Pseudoalignment and quantification were run on the aforementioned combined Kallisto index with parameters "—single—rf-stranded -l 100 -s 30 -s 30". TPM (transcript per million) and estimated counts at (pre-) transcript level were used for further analysis.

We filtered lowly expressed isoforms based on the expression level of the mature mRNA. Specifically, we calculated the Isoform Fraction (IF) for each transcript, which is defined as the TPM (transcript per million) of the isoform divided by the sum of TPM of all isoforms of a given gene. We defined a gene-specific threshold that depends on the number of annotated isoforms (n): the IF had to be greater than 1/n to be kept. Additionally, we set the maximal threshold to 0.2, such that when a gene has only two isoforms, if one contributes to more than 20% of the total expression, it was not filtered out. If a transcript met the condition in at least 6 samples out of the 60 samples (5 RNA populations, 12 time-points), it is kept.

In addition to the isoform-specific quantification, we pooled for each gene the isoforms belonging to the same biotype in order to have a biotype-specific quantification for each gene (sum of the estimated counts of the isoform belonging to the same biotype). As for the gene length used for normalisation, we calculated the weighted effective gene length (estimated by Kallisto), where weights were the expression levels of each isoform in each condition (therefore, gene length may slightly differ between RNA populations). We created 8 biotypes, based on the Ensembl description. Protein coding (PC), Retained Intron (RI), snRNA, and Processed Transcripts are defined by Ensembl. Nonsense mediated decay and non stop decay are grouped as "NMD". We grouped lincRNA, bidirectional promoter lncRNA, sense overlapping, sense intronic, 3prime overlapping ncRNA, lncRNA and in one biotype named "long non-coding RNA” (lncRNA). Small Nucleolar RNA (snoRNA) comprises the biotypes "snoRNA" and "scaRNA". All the biotypes containing the keyword "pseudogenes", whether they are processed, transcribed or not are grouped as "Pseudogene".

Finally, we also summed all the transcripts by gene, independently of their biotype, in order to obtain gene-wise quantification. The gene length was calculated as the weighted average based on the relative expression of all the isoforms in each RNA population.

For the analysis at steady-state (Figs 13 and S2 and S3 Tables), we normalised the estimated counts by Kallisto (S1 Table) into RPKM using the R package "DESeq2" [75]. This normalisation procedure was applied on each RNA population separately. We used the combined library size (pre-mRNA + mRNA) per sample to adjust for sequencing depth. The size factor was estimated using mRNA only, such that the median level of mRNA is aligned for all the samples. The same size factor was applied to the pre-mRNA, such that the relationship between pre-mRNA and mRNA is conserved. Here, we directly implemented a rhythmic analysis (harmonic regression) during the DESeq2 normalisation process, using the following model:

log2(μg,s,t)=ag,s*cos(w*ts)+bg,s*sin(w*ts)+intercept

where μg,s,t is the mean count of the negative binomial distribution for gene g for sample s at circadian time-point (ZT) ts. ag,s and bg,s are the coefficients of the cosine and sine functions, and w = 2 * π/ 24 h. The phase (peak of expression) is defined as tan-1(b/a) and the amplitude is (or log2 fold change) as a2 + b2. The full model with rhythmic parameters is tested with a Likelihood Ratio test against the reduced model with an intercept only. The intercept fitted by DESeq2 is used as the mean expression level over the 6 time points.

Finally, to express these expression levels in absolute mRNA counts per hepatocyte, we used the data in [4], where the authors converted the counts obtained from sequencing nuclear and cytoplasmic PolyA RNA from mouse liver into number of molecules per cell using smFISH. We applied a linear regression model on the log2-transformed RPKM and added the following log2 offsets to the NA, NT, CA and CT datasets: -1.34, -0.15, +1.2 and +0.7.

Modeling temporal RNA-seq profiles

To describe the accumulation of each RNA species in the nucleus and in the cytoplasm, we assumed that the pre-mRNA p is spliced and polyadenylated at a rate of s to produce mature nuclear RNA m. Then, m is exported at a rate e into the cytoplasm and becomes M, where it is finally degraded at a rate γ. We used NTI to approximate the level of pre-mRNA p, NAE and CAE to describe the accumulation of mature RNA in the nucleus m and in the cytoplasm M. We modeled the accumulations of m as a function of p, and of M as a function of m, with two separate ordinary differential equations:

dm(t)dt=sp(t)e(t)m(t) (1)
dM(t)dt=em(t)γ(t)M(t) (2)

To distinguish different modes of post-transcriptional regulation, we applied the model-based approach described in [12] on the two equations Briefly, e(t) and γ(t), respectively the export and cytoplasmic degradation rates, can be either constant (e(t) = e0 and γ(t) = γ0) or rhythmic (e(t) = e0(1 + εe cos(wt—φe)) and γ(t) = γ0(1+εγ cos(wt—φγ))), with w the angular frequency of 2π/24h-1, φ the phase (peak time) and ε the relative amplitude varying from 0 to 1. p(t) and m(t) are either constant (p(t) = p0 and m(t) = m0) or rhythmic (p(t) = pmin + Ap((1+cos(wt -φp))/2)β and m(t) = mmin + Am((1+cos(wt -φm)/2)β, with A the absolute amplitude (peak to trough), β ranging from 1 to 2, and φ the phase. Because NTI, NAE, and CAE come from samples processed and sequenced separately, the relative abundance is not defined, therefore, these parameters do not have a biologically interpretable value.

The following procedures and equations describe step 1, but are the same for step 2. To infer the values of the 8 parameters: Ap, Minp, φp, β, s, e0, εe and φe, we used the function optim from the R package "stats" with the method "L-BFGS-B". We assumed that RNA-seq counts data follows a binomial distribution [75]. Thus, the log-likelihood function to be minimised for each gene is:

log(L)=tlogNB((np(t)|μp(t),ap(t))+logNB(nm(t)|μm(t),am(t))

with

μp(t)=p(t)S(t)Lp
μm(t)=m(t)S(t)Lm

Here, n(t) is the read count, the subscripts p and m stand for pre-mRNA (NTI) and nuclear mRNA (NAE). α is the dispersion parameter of the negative binomial distribution, which is specific to each gene and time-point. It is estimated by the R package DESeq2 (fit type: "parametric") [75]. μ(t) is the expected mean of counts, which corresponds to the concentration of transcripts (p(t) and m(t)) multiplied by the gene length, and a sample-specific scaling factor S, and further multiplied by 109 to obtain numerically convenient values. The scaling factor S is first estimated by DESeq2 separately on each RNA population, including only mRNA, such that the median expression levels of mRNA are aligned between samples (Nuclear Total, Nuclear PolyA, and Cytoplasmic PolyA). The parameter e is bounded to 5 min to 12 h, and γ to 10 min to 24 h.

The combination of rhythmic / constant transcription and export terms generates 4 models (M1 to M4), each of them are fitted to experimental RNA-seq profiles and the most parsimonious model was chosen based on the Bayesian information criterion (BIC). The BIC is defined as:—log(L) + Klog(N), with K the number of parameters and N the number of datapoints. In order to discuss only unambiguously classified genes, we selected genes with a BIC probability (Schwarz weights) > 0.6.

Gene enrichment analysis

We defined genes that were nuclear and cytoplasmic enrichments using DESeq2 [75]: raw counts of NAE and CAE samples were tested for enrichment using the cellular localisation (Nuclear or Cytoplasmic) as a variable in the design formula (S4 Table). Contrary to the design used for S1 Table, time was not used as a variable in the formula. Genes with a log2FC >2 and an adjusted p-value <0.01 were considered as enriched in one of the compartments, which represents the top 15% most nuclear and most cytoplasmic genes. We tested for gene set enrichment of protein coding genes in nuclear and cytoplasmic fractions using Gene Ontology Terms derived from "Biological Processes". We tested the significance of the enrichment using Fisher’s exact test implemented in the EnrichR package [76] (version 3.0).

Single-molecule RNA-FISH

Dissected liver pieces were immediately fixed in 10% Neutral buffered Formalin (Sigma-Aldrich #HT5012) at 4C° for 24 to 36 hours. Fixed samples were then washed in PBS 1x for 30 min, and dehydrated in standard ethanol series followed by xylene bath, and finally embedded in paraffin (formalin fixed paraffin embedded, FFPE tissues). Sections were 8μm thick. Single-molecule RNA Fluorescent in situ Hybridisation (smFISH) experiments were performed using the RNAScope Multiplex Fluorescent Assay V2 (Advanced Cell Diagnostics #323100, Newark, USA), according to manufacturer’s instructions. Nuclei were counterstained with DRAQ fluorescent probe solution (Thermo Fisher Scientific #62251) for 10 min. Sections were mounted with ProLong Gold Antifade Mountant (Invitrogen #P36930). The Cry1 smFISH images were taken from [27] from liver cryosection and quantified for nuclear and cytoplasmic abundance. Catalogue number of the probes: Cry1: 500031, Per1: 438751, Arntl: 438741, Actb: 316741, Mlxipl: 558141.

Microscopy and image analysis

Sections were imaged with the Visitron Spinning Disk CSU W1 with a motorised stage. Z-stacks were acquired with a distance of 0.2μm between each Z position (~40 images per frame) with an oil immersion 63x objective. All z-stacks were maximally projected for analysis. The image analysis was performed using ImageJ ([77] software version 1.53c, Java 1.8.0_66). mRNA spots are detected by first applying a Gaussian blur, followed by the edge-detector Laplacian filter (FeatureJ). The local maxima—corresponding to the spots—are computed and counted. Nuclei are detected by applying a median blur filter, the Otsu method for automatic thresholding, and the watershed algorithm for segmentation. We quantified a density of mRNA per nuclei: we counted all the mRNAs present in one microscopy image and divided by the number of segmented nuclei.

Supporting information

S1 Fig. The ratio of nuclear pre-mRNA and mRNA reflects the relationship between transcription rate, splicing time, and export time.

A: NTI versus NAE, in log2(RPKM), averaged over 6 time points. According to our model, log2(NTI) is defined as log2(Transcription rate) + log2(pre-mRNA processing time (splicing and polyadenylation)) and log2(NAE) is defined as log2(Transcription rate) + log2(export time). In grey: kernel 2D density. Boxplots on top and on the right show the distribution of NTI and NAE. B: NTI / NAE ratio in log2-scale, defined as log2(splicing time)—log2(export time), against the average expression of NTI (up) or against NAE (bottom). Grey line indicates linear regression.

(TIF)

S2 Fig. Temporal profiles of genes classified as M3 in step 1.

25 profiles of genes classified as M3 (constant transcription, rhythmic export) according to the following criteria: all the genes have a log2FC > 0.8, and all classified as M2 or M4 in the analysis of step 2 (NAE vs CAE). Plots are arranged by the expression level of NAE (highest NAE Srrm2 in the upper left corner). Light blue dots and solid line: NAE, purple dots and dotted line: NTI.

(TIF)

S1 Table. RNA-seq counts of ribosome-depleted total RNA of nuclear, cytoplasmic, and unfractionated liver tissue, and polyadenylated RNA of nuclear and cytoplasmic liver tissue.

(XLSX)

S2 Table. Normalised RNA-seq counts of ribosome-depleted total RNA of nuclear, cytoplasmic, and unfractionated liver tissue, and polyadenylated RNA of nuclear and cytoplasmic liver tissue.

(XLSX)

S3 Table. Parameters of the linear harmonic regression on normalised RNA-seq counts of ribosome-depleted total RNA of nuclear, cytoplasmic, and unfractionated liver tissue, and polyadenylated RNA of nuclear and cytoplasmic liver tissue.

(XLSX)

S4 Table. GO Terms analysis of polyadenylated nuclear and cytoplasmic polyadenylated RNA.

(XLSX)

S5 Table. Estimated kinetic parameters and selected models at step 1 and step 2.

(XLSX)

Data Availability

All RNA-sequencing files are available from the Gene Expression Omnibus database (accession number: GSE182856)

Funding Statement

This work was supported by the Swiss National Science Foundation (SNSF) project grants 310030_173079 and 310030B_201267 (to F.N.), and the EPFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Chin A, Lécuyer E. RNA localization: Making its way to the center stage. Biochim Biophys Acta BBA—Gen Subj. 2017;1861: 2956–2970. doi: 10.1016/j.bbagen.2017.06.011 [DOI] [PubMed] [Google Scholar]
  • 2.Xia C, Babcock HP, Moffitt JR, Zhuang X. Multiplexed detection of RNA using MERFISH and branched DNA amplification. Sci Rep. 2019;9: 7721. doi: 10.1038/s41598-019-43943-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489: 101–108. doi: 10.1038/nature11233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bahar Halpern K, Caspi I, Lemze D, Levy M, Landen S, Elinav E, et al. Nuclear Retention of mRNA in Mammalian Tissues. Cell Rep. 2015;13: 2653–2662. doi: 10.1016/j.celrep.2015.11.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bhatt DM, Pandya-Jones A, Tong A-J, Barozzi I, Lissner MM, Natoli G, et al. Transcript Dynamics of Proinflammatory Genes Revealed by Sequence Analysis of Subcellular RNA Fractions. Cell. 2012;150: 279–290. doi: 10.1016/j.cell.2012.05.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Chen T, van Steensel B. Comprehensive analysis of nucleocytoplasmic dynamics of mRNA in Drosophila cells. PLoS Genet. 2017;13: e1006929. doi: 10.1371/journal.pgen.1006929 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, Giltnane JM, et al. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2001;2: research0041.1–research0041.11. doi: 10.1186/gb-2001-2-10-research0041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473: 337–342. doi: 10.1038/nature10098 [DOI] [PubMed] [Google Scholar]
  • 9.Zeisel A, Köstler WJ, Molotski N, Tsai JM, Krauthgamer R, Jacob-Hirsch J, et al. Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli. Mol Syst Biol. 2011;7: 529. doi: 10.1038/msb.2011.62 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rabani M, Pieper L, Chew G-L, Schier AF. A Massively Parallel Reporter Assay of 3′ UTR Sequences Identifies In Vivo Rules for mRNA Degradation. Mol Cell. 2017;68: 1083–1094.e5. doi: 10.1016/j.molcel.2017.11.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lück S, Thurley K, Thaben PF, Westermark PO. Rhythmic Degradation Explains and Unifies Circadian Transcriptome and Proteome Data. Cell Rep. 2014;9: 741–751. doi: 10.1016/j.celrep.2014.09.021 [DOI] [PubMed] [Google Scholar]
  • 12.Wang J, Symul L, Yeung J, Gobet C, Sobel J, Lück S, et al. Circadian clock-dependent and -independent posttranscriptional regulation underlies temporal mRNA accumulation in mouse liver. Proc Natl Acad Sci. 2018;115: E1916–E1925. doi: 10.1073/pnas.1715225115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB. A circadian gene expression atlas in mammals: Implications for biology and medicine. Proc Natl Acad Sci. 2014;111: 16219–16224. doi: 10.1073/pnas.1408886111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000;14: 2950–2961. doi: 10.1101/gad.183500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vollmers C, Gill S, DiTacchio L, Pulivarthy SR, Le HD, Panda S. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc Natl Acad Sci. 2009;106: 21453–21458. doi: 10.1073/pnas.0909591106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Weger BD, Gobet C, David FPA, Atger F, Martin E, Phillips NE, et al. Systematic analysis of differential rhythmic liver gene expression mediated by the circadian clock and feeding rhythms. Proc Natl Acad Sci. 2021;118. doi: 10.1073/pnas.2015803118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lowrey PL, Takahashi JS. Genetics of the Mammalian Circadian System: Photic Entrainment, Circadian Pacemaker Mechanisms, and Posttranslational Regulation. Annu Rev Genet. 2000;34: 533–562. doi: 10.1146/annurev.genet.34.1.533 [DOI] [PubMed] [Google Scholar]
  • 18.Shearman LP. Interacting Molecular Loops in the Mammalian Circadian Clock. Science. 2000;288: 1013–1019. doi: 10.1126/science.288.5468.1013 [DOI] [PubMed] [Google Scholar]
  • 19.Asher G, Schibler U. Crosstalk between Components of Circadian and Metabolic Cycles in Mammals. Cell Metab. 2011;13: 125–137. doi: 10.1016/j.cmet.2011.01.006 [DOI] [PubMed] [Google Scholar]
  • 20.Eckel-Mahan K, Sassone-Corsi P. Metabolism and the Circadian Clock Converge. Physiol Rev. 2013;93: 107–135. doi: 10.1152/physrev.00016.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Atger F, Gobet C, Marquis J, Martin E, Wang J, Weger B, et al. Circadian and feeding rhythms differentially affect rhythmic mRNA transcription and translation in mouse liver. Proc Natl Acad Sci. 2015;112: E6579–E6588. doi: 10.1073/pnas.1515308112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Koike N, Yoo S-H, Huang H-C, Kumar V, Lee C, Kim T-K, et al. Transcriptional Architecture and Chromatin Landscape of the Core Circadian Clock in Mammals. Science. 2012;338: 349–354. doi: 10.1126/science.1226339 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Menet JS, Rodriguez J, Abruzzi KC, Rosbash M. Nascent-Seq reveals novel features of mouse circadian transcriptional regulation. eLife. 2012;1: e00011. doi: 10.7554/eLife.00011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gotic I, Omidi S, Fleury-Olela F, Molina N, Naef F, Schibler U. Temperature regulates splicing efficiency of the cold-inducible RNA-binding protein gene Cirbp. Genes Dev. 2016;30: 2005–2017. doi: 10.1101/gad.287094.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Martelot GL, Canella D, Symul L, Migliavacca E, Gilardi F, Liechti R, et al. Genome-Wide RNA Polymerase II Profiles and RNA Accumulation Reveal Kinetics of Transcription and Associated Epigenetic Changes During Diurnal Cycles. PLOS Biol. 2012;10: e1001442. doi: 10.1371/journal.pbio.1001442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wang J, Mauvoisin D, Martin E, Atger F, Galindo AN, Dayon L, et al. Nuclear Proteomics Uncovers Diurnal Regulatory Landscapes in Mouse Liver. Cell Metab. 2017;25: 102–117. doi: 10.1016/j.cmet.2016.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mermet J, Yeung J, Hurni C, Mauvoisin D, Gustafson K, Jouffe C, et al. Clock-dependent chromatin topology modulates circadian transcription and behavior. Genes Dev. 2018;32: 347–358. doi: 10.1101/gad.312397.118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34: 525–527. doi: 10.1038/nbt.3519 [DOI] [PubMed] [Google Scholar]
  • 29.Benegiamo G, Mure LS, Erikson G, Le HD, Moriggi E, Brown SA, et al. The RNA-Binding Protein NONO Coordinates Hepatic Adaptation to Feeding. Cell Metab. 2018;27: 404–418.e7. doi: 10.1016/j.cmet.2017.12.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fazal FM, Han S, Parker KR, Kaewsapsak P, Xu J, Boettiger AN, et al. Atlas of Subcellular RNA Localization Revealed by APEX-Seq. Cell. 2019;178: 473–490.e26. doi: 10.1016/j.cell.2019.05.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007;8: 39. doi: 10.1186/1471-2164-8-39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009;33: 717–726. doi: 10.1016/j.molcel.2009.01.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zuckerman B, Ulitsky I. Predictive models of subcellular localization of long RNAs. RNA. 2019;25: 557–572. doi: 10.1261/rna.068288.118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Garneau NL, Wilusz J, Wilusz CJ. The highways and byways of mRNA decay. Nat Rev Mol Cell Biol. 2007;8: 113–126. doi: 10.1038/nrm2104 [DOI] [PubMed] [Google Scholar]
  • 35.Jackson DA, Pombo A, Iborra F. The balance sheet for transcription: an analysis of nuclear RNA metabolism in mammalian cells. FASEB J. 2000;14: 242–254. doi: 10.1096/fasebj.14.2.242 [DOI] [PubMed] [Google Scholar]
  • 36.Hocine S, Singer RH, Grünwald D. RNA Processing and Export. Cold Spring Harb Perspect Biol. 2010;2: a000752. doi: 10.1101/cshperspect.a000752 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Müller-McNicoll M, Neugebauer KM. How cells get the message: dynamic assembly and function of mRNA–protein complexes. Nat Rev Genet. 2013;14: 275–287. doi: 10.1038/nrg3434 [DOI] [PubMed] [Google Scholar]
  • 38.Palazzo AF, Lee ES. Sequence Determinants for Nuclear Retention and Cytoplasmic Export of mRNAs and lncRNAs. Front Genet. 2018;0. doi: 10.3389/fgene.2018.00440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gaidatzis D, Burger L, Florescu M, Stadler MB. Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation. Nat Biotechnol. 2015;33: 722–729. doi: 10.1038/nbt.3269 [DOI] [PubMed] [Google Scholar]
  • 40.Furlan M, Galeota E, Gaudio ND, Dassi E, Caselle M, Pretis S de, et al. Genome-wide dynamics of RNA synthesis, processing, and degradation without RNA metabolic labeling. Genome Res. 2020. [cited 2 Aug 2021]. doi: 10.1101/gr.260984.120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ameur A, Zaghlool A, Halvardson J, Wetterbom A, Gyllensten U, Cavelier L, et al. Total RNA sequencing reveals nascent transcription and widespread co-transcriptional splicing in the human brain. Nat Struct Mol Biol. 2011;18: 1435–1440. doi: 10.1038/nsmb.2143 [DOI] [PubMed] [Google Scholar]
  • 42.Hughes ME, DiTacchio L, Hayes KR, Vollmers C, Pulivarthy S, Baggs JE, et al. Harmonics of Circadian Gene Transcription in Mammals. PLOS Genet. 2009;5: e1000442. doi: 10.1371/journal.pgen.1000442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Sobel JA, Krier I, Andersin T, Raghav S, Canella D, Gilardi F, et al. Transcriptional regulatory logic of the diurnal cycle in the mouse liver. PLOS Biol. 2017;15: e2001069. doi: 10.1371/journal.pbio.2001069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Mor A, Suliman S, Ben-Yishay R, Yunger S, Brody Y, Shav-Tal Y. Dynamics of single mRNP nucleocytoplasmic transport and export through the nuclear pore in living cells. Nat Cell Biol. 2010;12: 543–552. doi: 10.1038/ncb2056 [DOI] [PubMed] [Google Scholar]
  • 45.Battich N, Stoeger T, Pelkmans L. Control of Transcript Variability in Single Mammalian Cells. Cell. 2015;163: 1596–1610. doi: 10.1016/j.cell.2015.11.018 [DOI] [PubMed] [Google Scholar]
  • 46.Xiong L, Ma Y, Tang L. Attenuation of transcriptional bursting in mRNA transport. Phys Biol. 2009;7: 016005. doi: 10.1088/1478-3975/7/1/016005 [DOI] [PubMed] [Google Scholar]
  • 47.Stoeger T, Battich N, Pelkmans L. Passive Noise Filtering by Cellular Compartmentalization. Cell. 2016;164: 1151–1161. doi: 10.1016/j.cell.2016.02.005 [DOI] [PubMed] [Google Scholar]
  • 48.Tani H, Mizutani R, Salam KA, Tano K, Ijiri K, Wakamatsu A, et al. Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals. Genome Res. 2012;22: 947–956. doi: 10.1101/gr.130559.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Khodor YL, Rodriguez J, Abruzzi KC, Tang C-HA, Marr MT, Rosbash M. Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila. Genes Dev. 2011;25: 2502–2512. doi: 10.1101/gad.178962.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Herzel L, Straube K, Neugebauer KM. Long-read sequencing of nascent RNA reveals coupling among RNA processing events. Genome Res. 2018;28: 1008–1019. doi: 10.1101/gr.232025.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tilgner H, Knowles DG, Johnson R, Davis CA, Chakrabortty S, Djebali S, et al. Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs. Genome Res. 2012;22: 1616–1625. doi: 10.1101/gr.134445.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Neugebauer KM. Nascent RNA and the Coordination of Splicing with Transcription. Cold Spring Harb Perspect Biol. 2019;11: a032227. doi: 10.1101/cshperspect.a032227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Khodor YL, Menet JS, Tolan M, Rosbash M. Cotranscriptional splicing efficiency differs dramatically between Drosophila and mouse. RNA. 2012;18: 2174–2186. doi: 10.1261/rna.034090.112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Yeom K-H, Pan Z, Lin C-H, Lim HY, Xiao W, Xing Y, et al. Tracking pre-mRNA maturation across subcellular compartments identifies developmental gene regulation through intron retention and nuclear anchoring. Genome Res. 2021; gr.273904.120. doi: 10.1101/gr.273904.120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Gordon JM, Phizicky DV, Neugebauer KM. Nuclear mechanisms of gene expression control: pre-mRNA splicing as a life or death decision. Curr Opin Genet Dev. 2021;67: 67–76. doi: 10.1016/j.gde.2020.11.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Saldi T, Cortazar MA, Sheridan RM, Bentley DL. Coupling of RNA polymerase II transcription elongation with pre-mRNA splicing. J Mol Biol. 2016;428: 2623–2635. doi: 10.1016/j.jmb.2016.04.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Braunschweig U, Barbosa-Morais NL, Pan Q, Nachman EN, Alipanahi B, Gonatopoulos-Pournatzis T, et al. Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 2014;24: 1774–1786. doi: 10.1101/gr.177790.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Drexler HL, Choquet K, Churchman LS. Splicing Kinetics and Coordination Revealed by Direct Nascent RNA Sequencing through Nanopores. Mol Cell. 2020;77: 985–998.e8. doi: 10.1016/j.molcel.2019.11.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Amarasinghe SL, Su S, Dong X, Zappia L, Ritchie ME, Gouil Q. Opportunities and challenges in long-read sequencing data analysis. Genome Biol. 2020;21: 30. doi: 10.1186/s13059-020-1935-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Mermet J, Yeung J, Naef F. Systems Chronobiology: Global Analysis of Gene Regulation in a 24-Hour Periodic World. Cold Spring Harb Perspect Biol. 2017;9: a028720. doi: 10.1101/cshperspect.a028720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Herzog VA, Reichholf B, Neumann T, Rescheneder P, Bhat P, Burkard TR, et al. Thiol-linked alkylation of RNA to assess expression dynamics. Nat Methods. 2017;14: 1198–1204. doi: 10.1038/nmeth.4435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Lugowski A, Nicholson B, Rissland OS. DRUID: a pipeline for transcriptome-wide measurements of mRNA stability. RNA. 2018;24: 623–632. doi: 10.1261/rna.062877.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Eisen TJ, Eichhorn SW, Subtelny AO, Lin KS, McGeary SE, Gupta S, et al. The Dynamics of Cytoplasmic mRNA Metabolism. Mol Cell. 2020;77: 786–799.e10. doi: 10.1016/j.molcel.2019.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.So WV, Rosbash M. Post-transcriptional regulation contributes to Drosophila clock gene mRNA cycling. EMBO J. 1997;16: 7146–7155. doi: 10.1093/emboj/16.23.7146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lee K-H, Kim S-H, Kim D-Y, Kim S, Kim K-T. Internal Ribosomal Entry Site-Mediated Translation Is Important for Rhythmic PERIOD1 Expression. PLOS ONE. 2012;7: e37936. doi: 10.1371/journal.pone.0037936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Morf J, Rey G, Schneider K, Stratmann M, Fujita J, Naef F, et al. Cold-Inducible RNA-Binding Protein Modulates Circadian Gene Expression Posttranscriptionally. Science. 2012;338: 379–383. doi: 10.1126/science.1217726 [DOI] [PubMed] [Google Scholar]
  • 67.Benegiamo G, Brown SA, Panda S. RNA Dynamics in the Control of Circadian Rhythm. In: Yeo GW, editor. RNA Processing: Disease and Genome-wide Probing. Cham: Springer International Publishing; 2016. pp. 107–122. doi: 10.1007/978-3-319-29073-7_5 [DOI] [PubMed] [Google Scholar]
  • 68.Du N-H, Arpat AB, De Matos M, Gatfield D. MicroRNAs shape circadian hepatic gene expression on a transcriptome-wide scale. Ptáček L, editor. eLife. 2014;3: e02510. doi: 10.7554/eLife.02510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Kojima S, Sher-Chen EL, Green CB. Circadian control of mRNA polyadenylation dynamics regulates rhythmic protein expression. Genes Dev. 2012;26: 2724–2736. doi: 10.1101/gad.208306.112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Baggs JE, Green CB. Nocturnin, a Deadenylase in Xenopus laevis Retina: A Mechanism for Posttranscriptional Control of Circadian-Related mRNA. Curr Biol. 2003;13: 189–198. doi: 10.1016/s0960-9822(03)00014-9 [DOI] [PubMed] [Google Scholar]
  • 71.Torres M, Becquet D, Blanchard M-P, Guillen S, Boyer B, Moreno M, et al. Circadian RNA expression elicited by 3’-UTR IRAlu-paraspeckle associated elements. Singer RH, editor. eLife. 2016;5: e14837. doi: 10.7554/eLife.14837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.El-Athman R, Fuhr L, Relógio A. A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal Cancer. eBioMedicine. 2018;33: 68–81. doi: 10.1016/j.ebiom.2018.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.El-Athman R, Knezevic D, Fuhr L, Relógio A. A Computational Analysis of Alternative Splicing across Mammalian Tissues Reveals Circadian and Ultradian Rhythms in Splicing Events. Int J Mol Sci. 2019;20: 3977. doi: 10.3390/ijms20163977 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.McGlincy NJ, Valomon A, Chesham JE, Maywood ES, Hastings MH, Ule J. Regulation of alternative splicing by the circadian clock and food related cues. Genome Biol. 2012;13: R54. doi: 10.1186/gb-2012-13-6-r54 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15: 550. doi: 10.1186/s13059-014-0550-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44: W90–97. doi: 10.1093/nar/gkw377 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9: 676–682. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory S Barsh, Achim Kramer

8 Dec 2021

Dear Dr Naef,

Thank you very much for submitting your Research Article entitled 'Comprehensive analysis of the circadian nuclear and cytoplasmic transcriptome in mouse liver' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Achim Kramer

Associate Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Many genes oscillate in a time of the day dependent manner – being regulated either directly through the cells circadian clock or through systemic signals such as body temperature cycles. While transcriptional regulation is classically considered the main source of oscillating gene expression, an important contribution of post-transcriptional mechanisms is likely. In the present manuscript the authors use RNAseq data of circadian liver samples thereby comparing nuclear and cytoplasmic PolyA+ and Ribo- libraries. The combination of these libraries allows the estimation of nuclear export and cytoplasmic degradation rates, and reveals many oscillating genes with rhythmic changes in these parameters. Overall the study is well designed and includes important control experiments.

I have a few minor points:

1) Page #5: The text says PC2 accounts for 17% of the variability (Figure: 14.7)

2) The authors sequenced polyA+ and Ribo- also of the cytoplasmic RNA. Are there considerable differences between rhythmic genes found in polyA+ vs Ribo- for the cytoplasm?

3) The PCA blot in Figure 1C shows a very nice clustering of the different libraries. Does this contain all timepoints and could the timepoints be labeled?

4) Page #9: Is Gck with a negative log2 of -1.2 nuclear enriched? What is the cut-off?

5) In the text the authors use r values while the figures depict R² values. Could they decide for one?

6) All linear regression fits show an identical p Value of < 2.2e-16. Even if almost no correlation is visible. Is this still correct (due to the high n number?)

7) Page #15: In Fig 4D…. Is this not 4F?

8) Fig. 4B: Why is in model 2 the pre-mRNA higher expressed then the mRNA?

9) In Figure 5 the authors compare rhythmic nuclear RNAs. Based on panel E these also show rhythms in the cytoplasm. Is this with the same acrophase?

10) Based on 4D many NAE rhythmic transcripts show a low amplitude. Could the authors comment how reliably these can be predicted (especially with n=2 I would estimate some false positive genes).

11) The authors mention a spike in rat RNA. Could they comment why this was not used for normalization. Would this result in comparable results?

Reviewer #2: In the manuscript entitled “Comprehensive analysis of the circadian nuclear and cytoplasmic transcriptome in mouse liver”, Hurni et al. generate and analyze new circadian datasets from cellular fractions obtained from mouse liver and determined the kinetics of gene expression. Briefly, the authors extract RNA from nuclear and cytoplasmic fractions of mouse livers collected at different times of the day (every 4 hours) and use it to generate polyA and total RNAseq libraries which they sequence. By plugging the data into several mathematical models, the authors can determine not only genes displaying rhythmic transcription and steady state levels (as done previously by many including the Naef lab) but also degradation, splicing and nuclear export rates. Among the many findings the authors uncover a role for nuclear export in generating and modulating circadian gene expression.

The present manuscript presents both very interesting datasets as well as findings regarding not only circadian gene expression but also how gene expression in general can be modulated at the different levels. While some of the findings might seem only confirmatory, the present study is solid and constitute a body of work that should be published and shared with the scientific community. So, I strongly support publication in PLoS Genetics with minor revisions.

Minor Concerns

- Most of the results are based on the analysis of RNAseq datasets. In this context it would be good if the authors could speculate how the oscillations of the genes in the M4 group is generated.

- The fact that splicing seems less efficient in longer genes is no surprising. Maybe the authors could interpret this in the context of effects of transcriptional elongation on cotranscriptional splicing.

Reviewer #3: Hurni et al. produced time series RNA-seq data sets from fractionated mouse liver cells and used the obtained RNA measurements to build a mathematical model, which allows to investigate RNA processing steps namely nuclear export and cytoplasmic degradation. Furthermore, they also studied the proportion of co-transcriptionally and post-transcriptionally spliced genes through the intronic signals present within nuclear total pre-mRNA and the nuclear polyadenylated pre-mRNA and reported a strong correlation between gene length (using only protein coding transcripts) and the tendency towards co-transcriptional or post-transcriptional splicing.

Overall, I found the idea driving this work to be interesting. Valuable data sets were produced, which will be appreciated by others investigating circadian regulation underlying RNA processing steps. Potentially interesting results, though still preliminary, are presented. I have a few major and minor concerns which should be addressed before publication.

Major concerns:

1- Overall, I found that the main conclusions are often hidden in a description of the methodology. This is often the case in the results section where the authors frequently describe the methods, but not the interpretation of the results presented.

2- In the discussion a summary of the results is presented, but little is mentioned regarding the contextualization of these results within the landscape of published data. This is particularly evident when referring to the splicing findings. The literature on circadian regulation of splicing seems to have been, to a large extend, neglected (e.g. McGlincy NJ, et al. Genome Biol. 2012. doi: 10.1186/gb-2012-13-6-r54;. Benegiamo, G. et al RNA Process; Springer, 2016; pp. 107–122.; El-Athman R, et al. EBioMedicine. 2018. doi: 10.1016/j.ebiom.2018.06.012; Torres M, et al. Wiley Interdiscip Rev RNA. 2018 doi: 10.1002/wrna.1467).

3- How much of the findings apply only to the liver (which is of course fine and to some degree expected)? Alternative splicing is known to show tissue specificity (Baralle, F et al. Nat. Rev. Mol. Cell Biol. 2017) and also circadian regulation seems to be tissue specific (Litovchenko M, et al. Sci Adv. 2021 Jan 29;7(5):eabc3781. doi: 10.1126/sciadv.abc3781.; Harder L, et al. Bioessays. 2020 May;42(5):e1900158. doi: 10.1002/bies.201900158.). Can the authors use published mammalian circadian data sets to verify some of their conclusion, or to compare the outcomes using different tissues?

4- Related to the previous comment: it is relevant to specify, for the different conclusion, that the current findings apply only to liver tissues. I assume that the RNAseq data is submitted to a public repository, however this is not indicated nor is an accession number provide, which could be used to retrieve the data, after publication of the manuscript.

5- Some references are missing, for e.g. the authors write “…to couple circadian genes and physiological pathways.”, pg 3, a reference would be needed.

6- The authors present a circadian analysis based on the expression of the genes, yet often the individual transcripts oscillate, but when summarizing their expression, the result is a non-oscillating gene (expression), this of course will influence the conclusions and should be taken into account, in particular considering the underlying splicing analysis.

7- It is often not clear which isoform of a certain gene is being considered and several of the genes mentioned have more than one isoform.

8- How would the authors account for alternative splicing using their model, or are they considering simply one transcript per pre-RNA, and if yes, what would be the rationale to ignore alternative splicing events?

9- The authors refer to “splicing time” how is splicing time determined and how was it validated?

10- The authors refer to Correlation coefficient (r) values in the results section, I could not find a description for the type of correlation computed. Overall the information regarding statistics is lacking throughout the manuscript. The authors show (e.g. Fig 4) potentially oscillating genes, but do not provide p-values/adjusted p-values for the significance of such oscillation. Also in Fig 4F in some plots an error for the half-life values is provided and in some not. The information regarding what type of error this is (e.g. SD, SEM) is missing, as well as which N was used.

11- In Fig 6 D, F it is not clear how many nuclei were used for the quantification, statistics are also missing to evaluate whether the apparent differences observed are significant.

12- Which splicing factors are the authors considering for their analysis? For e.g. in Fig 2 the authors refer to “splicing (SR family members)”, but this would be a rather reductionist view of the group of splicing factors, it should be made clear in the manuscript which SFs are being considered.

13- The authors mentioned changes in the circadian profile of splicing factors such as Hnrnph1 or Srsf1, where alterations in spliceosome complex elements such as U2af1 detected?

14- In the results section, the authors mentioned that “The splicing regime is strongly influenced by the gene length, or more precisely by the relation of splicing and elongation time”. However, the authors have only focused on the transcripts with protein coding biotypes during this analysis, thus it should be specified that this conclusion is only valid for such transcripts.

15- What was the rationale to focus on PARBZip family members?

16- Have the authors found a correlation between the number of transcripts (or maybe number of circadian transcripts) from a given gene and co- vs post-transcriptional splicing?

Minor concerns:

• In the Methods section, the catalogue numbers, company names, and locations are missing.

• Figure 1, panel E: It is currently difficult to differentiate between dashed and solid lines (exon and introns).

• There are few typos in the manuscript e.g. “bioype”, “focussing”.

• The magnification details for the microscopy pictures is missing (Figure 6).

• Missing axis labels in Figure 6A, Figure S2.

• In the Microscopy and image analysis, missing “analysis” in the sentence “the image was performed using ImageJ”.

• Missing details on ImageJ and microscope software version.

Overall, the study design and purpose are interesting, but a better description and interpretation of the results is needed to highlight the major outcomes, as well as improving the contextualization and association of ideas in the discussion.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: No: RNA sequencing data are not publically available

Reviewer #2: Yes

Reviewer #3: No: RNA seq data should be deposited in a public repository

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Decision Letter 1

Gregory S Barsh, Achim Kramer

3 May 2022

Dear Felix,

Thank you very much for submitting your Research Article entitled 'Comprehensive analysis of the circadian nuclear and cytoplasmic transcriptome in mouse liver' to PLOS Genetics. The revised manuscript was seen by reviewer #3. They (and we) are enthusiastic about the work and are prepared to move forward with acceptance. However, there are some minor concerns from reviewer #3 that we ask you to address in a final round of minor revision that should not require additional external review.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Achim Kramer

Associate Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #3: Hurni et al. have revised the manuscript following the recommendations of the reviewers. I have carefully read the rebuttal letter and the replies to the comments of the three reviewers, which I found clear and convincing. I would also like to praise the authors for carrying out additional analysis and introducing several clarifications and additional discussion.

This is a very interesting work, which fully deserves publication in PLOS Genetics. I have though a few minor comments, all related to discrepancies between the rebuttal letter and the revised version of the manuscript, which the authors can easily solve.

I fully agree with all the replies from the authors in the rebuttal letter, however, for some of the points, I could not find, in the version of the manuscript with corrections marked, the corresponding additions/clarifications, or not as clear and as detailed as in the letter. Thus, I would ask the authors to carefully compare rebuttal vs manuscript for the points listed below where I use the same numbering as in the rebuttal letter.

2- In the discussion a summary of the results is presented, but little is mentioned regarding the contextualization of these results within the landscape of published data. This is particularly evident when referring to the splicing findings. The literature on circadian regulation of splicing seems to have been, to a large extend, neglected (e.g. McGlincy NJ, et al. Genome Biol. 2012. doi: 10.1186/gb-2012-13-6-r54;. Benegiamo, G. et al RNA Process; Springer, 2016; pp. 107–122.; El-Athman R, et al. EBioMedicine. 2018. doi: 10.1016/j.ebiom.2018.06.012; Torres M, et al. Wiley Interdiscip Rev RNA. 2018 doi: 10.1002/wrna.1467).

Reply: (…) Nevertheless, we agree that a better discussion of the literature on circadian alternative splicing was necessary and have now included the discussion of the listed references.

8- How would the authors account for alternative splicing using their model, or are they considering simply one transcript per pre-RNA, and if yes, what would be the rationale to ignore alternative splicing events?

Reply: (…) The fact that different isoforms may have different rhythmic patterns that would be hidden at the gene-level is now clearly mentioned in the discussion, and we referenced relevant papers (El-Athman et al. 2019).

9- The authors refer to “splicing time” how is splicing time determined and how was it validated?

Reply: (…). These points have been clarified in the discussion section, as also suggested under points 2 and 3 from this reviewer.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Decision Letter 2

Gregory S Barsh, Achim Kramer

6 Jul 2022

Dear Felix,

We are pleased to inform you that your manuscript entitled "Comprehensive analysis of the circadian nuclear and cytoplasmic transcriptome in mouse liver" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Achim Kramer

Associate Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-01403R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory S Barsh, Achim Kramer

31 Jul 2022

PGENETICS-D-21-01403R2

Comprehensive analysis of the circadian nuclear and cytoplasmic transcriptome in mouse liver

Dear Dr Naef,

We are pleased to inform you that your manuscript entitled "Comprehensive analysis of the circadian nuclear and cytoplasmic transcriptome in mouse liver" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Olena Szabo

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. The ratio of nuclear pre-mRNA and mRNA reflects the relationship between transcription rate, splicing time, and export time.

    A: NTI versus NAE, in log2(RPKM), averaged over 6 time points. According to our model, log2(NTI) is defined as log2(Transcription rate) + log2(pre-mRNA processing time (splicing and polyadenylation)) and log2(NAE) is defined as log2(Transcription rate) + log2(export time). In grey: kernel 2D density. Boxplots on top and on the right show the distribution of NTI and NAE. B: NTI / NAE ratio in log2-scale, defined as log2(splicing time)—log2(export time), against the average expression of NTI (up) or against NAE (bottom). Grey line indicates linear regression.

    (TIF)

    S2 Fig. Temporal profiles of genes classified as M3 in step 1.

    25 profiles of genes classified as M3 (constant transcription, rhythmic export) according to the following criteria: all the genes have a log2FC > 0.8, and all classified as M2 or M4 in the analysis of step 2 (NAE vs CAE). Plots are arranged by the expression level of NAE (highest NAE Srrm2 in the upper left corner). Light blue dots and solid line: NAE, purple dots and dotted line: NTI.

    (TIF)

    S1 Table. RNA-seq counts of ribosome-depleted total RNA of nuclear, cytoplasmic, and unfractionated liver tissue, and polyadenylated RNA of nuclear and cytoplasmic liver tissue.

    (XLSX)

    S2 Table. Normalised RNA-seq counts of ribosome-depleted total RNA of nuclear, cytoplasmic, and unfractionated liver tissue, and polyadenylated RNA of nuclear and cytoplasmic liver tissue.

    (XLSX)

    S3 Table. Parameters of the linear harmonic regression on normalised RNA-seq counts of ribosome-depleted total RNA of nuclear, cytoplasmic, and unfractionated liver tissue, and polyadenylated RNA of nuclear and cytoplasmic liver tissue.

    (XLSX)

    S4 Table. GO Terms analysis of polyadenylated nuclear and cytoplasmic polyadenylated RNA.

    (XLSX)

    S5 Table. Estimated kinetic parameters and selected models at step 1 and step 2.

    (XLSX)

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers_resubmission.docx

    Data Availability Statement

    All RNA-sequencing files are available from the Gene Expression Omnibus database (accession number: GSE182856)


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES